Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 429-434

  Huang, Jianlin ^a   Xie, Baozhao ^a,b   Li, Qiuxia ^a   Xie, Xujing ^a   Zhu, Shangling ^a   Wang, Mingxia ^a   Peng, Weixiang ^a   Gu, Jieruo ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

CD147; Infliximab; Matrix metalloproteinase; Rheumatoid arthritis; Therapy

Indexed keywords

CD147 ANTIGEN; GELATINASE B; INFLIXIMAB; MESSENGER RNA; METHOTREXATE; PLACEBO; STROMELYSIN;

ADULT; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MULTIPLEXED MICROSPHERE BASED FLOW ASSAY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; ANTIGENS, CD147; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MONOCYTES; RNA, MESSENGER;

EID: 84871921119     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.10.030     Document Type: Article

References (30)

1. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, and A. Et The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum. 31 1988 315 324 (Pubitemid 18091653)
2. C. Biswas, Y. Zhang, R. DeCastro, H. Guo, T. Nakamura, H. Kataoka, and K. Nabeshima The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily Cancer Res. 55 1995 434 439
3. F.M. Brennan, and I.B. McInnes Evidence that cytokines play a role in rheumatoid arthritis J. Clin. Invest. 118 2008 3537 3545
4. G.S. Firestein, J.M. Alvaro-Gracia, and R. Maki Quantitative analysis of cytokine gene expression in rheumatoid arthritis J. Immunol. 144 1990 3347 3353 (Pubitemid 20146364)
5. J. Fransen, and P.L. van Riel The disease activity score and the EULAR response criteria Clin. Exp. Rheumatol. 23 2005 S93 S99
6. M.J. Green, A.K. Gough, J. Devlin, J. Smith, P. Astin, D. Taylor, and P. Emery Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis Rheumatology (Oxford) 42 2003 83 88 (Pubitemid 36131572)
7. H. Guo, R. Li, S. Zucker, and B.P. Toole EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface Cancer Res. 60 2000 888 891 (Pubitemid 30129521)
8. H. Hamakawa, M. Takemura, M. Sato, R. Shinohe, H. Koishi, N. Furuta, H. Ohta, N. Koike, N. Iwamoto, Y. Yamada, H. Wada, K. Saito, and M. Seishima Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers (IL-6, IL-8) Rinsho Byori 51 2003 13 18
9. J. Jia, C. Wang, Z. Shi, J. Zhao, Y. Jia, Z. Zhao-Hui, X. Li, Z. Chen, and P. Zhu Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis Rheumatology (Oxford) 48 2009 721 726
10. L. Klareskog, A.I. Catrina, and S. Paget Rheumatoid arthritis Lancet 373 2009 659 672
11. Y.T. Konttinen, T.F. Li, J. Mandelin, M. Liljestrom, T. Sorsa, S. Santavirta, and I. Virtanen Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium Arthritis Rheum. 43 2000 275 280 (Pubitemid 30395735)
12. P.E. Lipsky, D.M. van der Heijde St, C.E. Furst, D.E. Breedveld, F.C. Kalden, J.R. Smolen, J.S. Weisman, M. Emery, P. Feldmann, M. Harriman, and G.R. Maini, R.N. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group N. Engl. J. Med. 343 2000 1594 1602
13. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
14. R.N. Maini, F.C. Breedveld, J.R. Kalden, J.S. Smolen, D. Davis, J.D. Macfarlane, C. Antoni, B. Leeb, M.J. Elliott, J.N. Woody, T.F. Schaible, and M. Feldmann Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum. 41 1998 1552 1563 (Pubitemid 28459913)
15. R.N. Maini, M.J. Elliott, F.M. Brennan, R.O. Williams, C.Q. Chu, E. Paleolog, P.J. Charles, P.C. Taylor, and M. Feldmann Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease Immunol. Rev. 144 1995 195 223
16. U. Muller-Ladner, and S. Gay MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction? Ann. Rheum. Dis. 61 2002 957 959 (Pubitemid 35221681)
17. H. Nagasawa, H. Kameda, N. Sekiguchi, K. Amano, and T. Takeuchi Improvement of the HAQ score by infliximab treatment in patients with RA: its association with disease activity and joint destruction Mod. Rheumatol. 19 2009 166 172
18. A. Pfeil, J. Lippold, T. Eidner, G. Lehmann, P. Oelzner, D.M. Renz, A. Hansch, G. Wolf, G. Hein, W.A. Kaiser, and J. Bottcher Effects of leflunomide and methotrexate in rheumatoid arthritis detected by digital X-ray radiogrammetry and computer-aided joint space analysis Rheumatol. Int. 29 2009 287 295
19. M.J. Plant, P.W. Jones, J. Saklatvala, W.E. Ollier, and P.T. Dawes Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study J. Rheumatol. 25 1998 417 426 (Pubitemid 28109339)
20. K. Redlich, S. Hayer, R. Ricci, J.P. David, M. Tohidast-Akrad, G. Kollias, G. Steiner, J.S. Smolen, E.F. Wagner, and G. Schett Osteoclasts are essential for TNF-alpha-mediated joint destruction J. Clin. Invest. 110 2002 1419 1427 (Pubitemid 35396913)
21. N. Ruperto, D.J. Lovell, R. Cuttica, P. Woo, S. Meiorin, C. Wouters, E.D. Silverman, Z. Balogh, M. Henrickson, J. Davidson, I. Foeldvari, L. Imundo, G. Simonini, J. Oppermann, S. Xu, Y.K. Shen, S. Visvanathan, A. Fasanmade, A. Mendelsohn, A. Martini, and E.H. Giannini Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension Ann. Rheum. Dis. 69 2010 718 722
22. Saag, K.G., Teng, G.G., Patkar, N.M., Anuntiyo, J., Finney, C., Curtis, J.R., Paulus, H.E., Mudano, A., Pisu, M., Elkins-Melton, M., Outman, R., Allison, J.J., Suarez, A.M., Bridges, S.J.,Chatham, W.W., Hochberg, M., MacLean, C., Mikuls, T., Moreland, L.W., O'Dell, J., Turkiewicz, A.M., Furst, D.E., 2008. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 59, 762-784. (Pubitemid 351847559)
23. J.S. Smolen, R. Landewe, F.C. Breedveld, M. Dougados, P. Emery, C. Gaujoux-Viala, S. Gorter, R. Knevel, J. Nam, M. Schoels, D. Aletaha, M. Buch, L. Gossec, T. Huizinga, J.W. Bijlsma, G. Burmester, B. Combe, M. Cutolo, C. Gabay, J. Gomez-Reino, M. Kouloumas, T.K. Kvien, E. Martin-Mola, I. McInnes, K. Pavelka, P. van Riel, M. Scholte, D.L. Scott, T. Sokka, G. Valesini, R. van Vollenhoven, K.L. Winthrop, J. Wong, A. Zink, and D. van der Heijde EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs Ann. Rheum. Dis. 69 2010 964 975
24. I. Tchetverikov, L.R. Lard, J. DeGroot, N. Verzijl, J.M. TeKoppele, F.C. Breedveld, T.W. Huizinga, and R. Hanemaaijer Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis Ann. Rheum. Dis. 62 2003 1094 1099 (Pubitemid 37323575)
25. S.L. Teitelbaum Bone resorption by osteoclasts Science 289 2000 1504 1508
26. T. Tomita, T. Nakase, M. Kaneko, K. Shi, K. Takahi, T. Ochi, and H. Yoshikawa Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis Arthritis Rheum. 46 2002 373 378 (Pubitemid 34136574)
27. S.M. van der Kooij, S. le Cessie, Y.P. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, D. van Zeben, P.J. Kerstens, J.M. Hazes, D. van Schaardenburg, F.C. Breedveld, B.A. Dijkmans, and C.F. Allaart Clinical and radiological efficacy of initial vs. delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis Ann. Rheum. Dis. 68 2009 1153 1158
28. N. Yukawa, and T. Mimori Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis Clin. Calcium 19 2009 395 403
29. P. Zhu, J. Ding, J. Zhou, W.J. Dong, C.M. Fan, and Z.N. Chen Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production Arthritis Res. Ther. 7 2005 R1023 R1033
30. P. Zhu, N. Lu, Z.G. Shi, J. Zhou, Z.B. Wu, Y. Yang, J. Ding, and Z.N. Chen CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes Arthritis Res. Ther. 8 2006 R44